MONROVIA, Calif.--(BUSINESS WIRE)--
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer
and marketer of implantable lenses and companion delivery systems for
the eye, today announced a multi-year Strategic Alliance Agreement with
Dr. Tobias Neuhann of the Augenklinik am Marienplatz (Eye Clinic at
Marienplatz) in Munich, Germany. The agreement serves as a global
partnership model for smaller and single site refractive surgery eye
clinics that aim to provide STAAR's EVO Visian ICL™ intraocular lenses
as a primary and premium option for patients seeking visual freedom from
spectacles and contact lenses.
This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20181009005172/en/
EVO Visian ICL Flying Phantom (Photo: Business Wire)
Caren Mason, President & CEO of STAAR, stated, “Our agreement with Dr.
Tobias Neuhann highlights the collaborative excellence possible between
STAAR and ophthalmologists operating clinics outside large hospital,
university and multi-site settings. Offering many of the benefits of our
larger strategic cooperation agreements to these clinics is an important
component of STAAR’s growth strategy. Dr. Neuhann is a pioneer with a
long history of excellence working with the ICL including our latest
generation of the EVO family of lenses. His passion for the ICL is
shared by his family. His son, Raphael Neuhann, is on staff at
Augenklinik am Marienplatz as a dedicated ICL surgeon. The family also
loves sailing and sails a Flying Phantom catamaran as part of an EVO
Visian ICL branded sailing team. The catamaran prominently features EVO
as part of STAAR’s 'Break Free From Glasses' campaign and illustrates
one aspect of our company’s creative approach to marketing with our
ophthalmology customers. We are thrilled to formally expand our
collaboration with this highly-regarded doctor and his family’s clinic.”
“My clinic and staff look forward to further deepening our relationship
with STAAR and its stellar family of ICL lenses as an official Strategic
Alliance Partner. We are committed to providing STAAR’s ICL lens, and
the associated implantation procedure that preserves the natural anatomy
of the eye, as a primary and premium option for patients wanting to
experience high quality vision,” stated Dr. Tobias Neuhann, Practice
Owner and Medical Head of Augenklinik am Marienplatz. “I have
successfully implanted the ICL lenses in my wife’s eyes and hundreds of
additional patients seeking visual freedom from spectacles and contact
lenses. We believe the additional patient education, marketing and
support provided by STAAR under this strategic alliance will facilitate
our commitment to accelerating the growth of the ICL in our practice,”
concluded Dr. Neuhann.
In January 2016STAAR Surgical Company announced the first Strategic
Cooperation Agreements with two of the largest and most respected eye
hospitals in the world. The Strategic Alliance Agreement with Dr. Tobias
Neuhann of the Augenklinik am Marienplatz includes similar marketing,
patient education and surgeon training support provided by STAAR. The
agreements are tailored and optimized for the unique needs of smaller
and single site refractive centers while providing STAAR with committed
levels of growth by the clinic and premium and primary positioning of
the ICL family of lenses.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 30
years, designs, develops, manufactures and markets implantable lenses
for the eye with companion delivery systems. These lenses are intended
to provide visual freedom for patients, lessening or eliminating the
reliance on glasses or contact lenses. All of these lenses are foldable,
which permits the surgeon to insert them through a small incision.
STAAR’s lens used in refractive surgery is called an Implantable
Collamer® Lens or “ICL”, which includes the EVO Visian ICL™ product
line. More than 900,000 Visian ICLs have been implanted to date. To
learn more about the ICL go to: www.discovericl.com.
STAAR has approximately 400 full-time equivalent employees and markets
lenses in over 75 countries. Headquartered in Monrovia, CA, the company
operates manufacturing facilities in Aliso Viejo, CA and Monrovia, CA.
For more information, please visit the Company’s website at www.staar.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181009005172/en/
Investors & Media
EVC Group
Brian Moore,
310-579-6199
Doug Sherk, 415-652-9100
Source: STAAR Surgical Company
